40
Views
69
CrossRef citations to date
0
Altmetric
Research Article

Low predictive value of intrinsic fibroblast radiosensitivity for fibrosis development following radiotherapy for breast cancer

, , , , , & show all
Pages 661-670 | Published online: 03 Jul 2009

  • AGREN, A., BRAHME, A. and TURBSSON, I., 1990, Optimization of uncomplicated control for head and neck tumors. internationalJ ournal of Radiation Oncology, Biology, Physics, 19, 1077-1085.
  • BBGG, A. C., HOFLAND, I., VAN GLABBEKB, M., BARTELINK, H. and HORIOT, J. C., 1992, Predictive value of potential doubling time for radiotherapy of head and neck tumour patients: results from the EORTC cooperative trial 22851. Seminars in Radiation Oncology, 1, 22-25.
  • BEGG, A. C., RUSSELL, N. S., KNAKEN, H. and LEBBSQUB, J. V., 1993, Lack of correlation of human fibroblast radiosensitivity in vitro with early skin reactions in patients undergoing radiotherapy. International Journal of Radiation Biology, 64, 393-405.
  • BENTZEN, S. M., TURESSON, I. and THAMES, H. D., 1990, Fractionation sensitivity and latency of telangiectasia after postmastectomy radiotherapy: a graded response analysis. Radiotherapy and Oncology, 18, 95-106.
  • BENTZEN, S. M., OVBRGAARD, J. and OVERGAARD, M., 1993, Clinical correlations between late normal tissue endpoints after radiotherapy: implications for predictive assays of radiOSensitivity. European Journal of Cancer, 29A,1373-1376.
  • BBNTZEN, S. M., SKOCZYLAS, J. Z., OVERGAARD, M. and OVBRGAARD, J., 1996, Radiotherapy-related lung fib rosis enhanced by tamoxifen. Journal of the National Cancer institute, 88, 918-922.
  • BENTZEN, S. M., 1997, Potential clinical impact of normal-tissue intrinsic radiOSensitivity testing. Radiotherapy and Oncology,43, 121-131.
  • BORGER, J., KEMPERMAN, H., HART, A., PBTERSE, J., VAN DONGEN, J. and BARTELINK, H., 1994a, Risk factors in breast conservation therapy, journal of clinical Oncology, 12, 653-660.
  • BORGER, J. H., KEMPERMAN, H., SILLEVIS SMITT, H., HART, A., VAN DoNGEN9J., LEBESQUE, J.and BARTELINK, H., 1994b, Dose and volume effects on fib rosis after breast conservation therapy, lniernational Journal of Radiation Oncology, Biology, Physics, 30, 1073-1081.
  • BROCK, W. A., TUCKER, S. L., GEARA, F. B., TURBSSON, L, WIKE, J., NYMAN, J. and PETERS, L. J., 1995, Fibroblast radiOSensitivity versus acute and late normal skin responses in patients treated for breast cancer, international J ournal of Radiation Oncology. Biology, Physics, 32, 1371-1379.
  • BURNET, N. G., NYMAN, J., TURBSSON, I., WURM, R., YARNOLD, J. R. and PEACOCK, J. H., 1992, Prediction of normaltissue tolerance to radiotherapy from in vitro cellular radiation sensitivity. The Lancet, 339, 1570-1571.
  • BURNBT, N. G., NYMAN, J., TURBSSON, I., WURM, R., YARNOLD, J. R. and PEACOCK, J. H., 1994, The relationship between cellular radiation sensitivity and tissue response may provide the basis for individualising radiotherapy schedules. Radiotherapy and Oncology, 33, 228-238.
  • BURNBT, N. G., WURM, R., NYMAN, J. and PEACOCK, J. H., 1996, Normal tissue radiosensitivity - How important is it? Clinical Oncology, 8, 25-34.
  • CICCHETTI, D. V. and ALLISON, T., 1971, A new procedure for assessing reliability of scoring EEG sleep recordings. American Journal of EEC, Technology, 11, 101-109.
  • GEARA, F. B., PETERS, L. J., KIAN ANG, K., WIKE, J. L., SIVON, S. S., GUTTENBBRGER, R., CALLENDER, D. L., MALAISE, E. P. and BROCK, W. A., 1992, Intrinsic radiosensitivity of normal human fib rob lasts and lymphocytes after highand low-dose-rate irradiation. Cancer Research, 52, 6348-6352.
  • GEARA, F. B., PETERS, L. J., KIAN ANG, K., WIKE, J. L. and BROCK, W. A., 1993, Prospective comparison of in vitro normal cell radiosensitivity and normal tissue reactions in radiotherapy patients. International Journal of Radiation Oncology. Biology. Physics, 27, 1173-1179.
  • HOCKEL, M., SCHLENGBR, K., ARAL, B., MITZB, M., SCHAFFBR, U. and VAUFEL, P., 1996, Association between tumour hypoxia and malignant progression in advanced cancer of the uterine cervix. Cancer Research, 56, 4509-4515.
  • JOHANSEN, J., BENTZEN, S. M., OVBRGAARD, J. and OVBRGAARD, M., 1994, Evidence for a positive correlation between in »(n> radiosensitivity of normal human skin fib rob lasts and the occurrence of subcutaneous fib rosis after radiotherapy. International Journal of Radiation Biology, 66, 407-412.
  • JOHANSEN, J., BBNTZBN, S. M., OVERGAARD, J. and OVERGAARD, M., 1996, Relationship between the in vitro radiosensitivity of skin fibroblasts and the expression of subcutaneous fib rosis, telangiectasia, and skin erythema after radiotherapy. Radiotherapy and Oncology, 40, 101-109.
  • LITTLE, J. B. and NOVE, J., 1990, Sensitivity of human diploid fibroblast cell strains from various genetic disorders to acute and protracted radiation exposure. Radiation Research, 123, 87-92.
  • NAGASAWA, H., LITTLE, J. B., TSANG, N. M., SAUNDERS, E., TESMER, J. and STRNISTE, G. F., 1992, Effect of dose rate on the survival of irradiated human skin fibroblasts. Radiation Research, 132, 375-379.
  • NORMAN, A., KAGAN, A. R. and CHAN, S. L., 1988, The importance of genetics for the optimization of radiation therapy. American J ournal of Clinical Oncology, U, 84-88.
  • PETERS, L. J., 1996, Radiation therapy tolerance limits for one or for all? Cancer, 77, 2379-2385.
  • POMP, J., WIKE, J. L., OUWERKERK, I. J. M., HOOGSTRATEN, C., DAVELAAR, J., SCHRIER, P. I., LEER, J. W. H., THAMES, H. D. and BROCK, W. A., 1996, Cell density dependent plating efficiency affects outcome and interpretation of COlony forming assays. Radiotherapy and Oncology, 40, 121-125.
  • RAAPHORST, G. P., 1993, Prediction of radiotherapy response using SF2: is it methodology or mythology? Radiotherapy and Oncology, 28, 187-188.
  • RUSSELL, N. S., ARLETT, C. F., BARTELINK, H. and BEGG, A. C., 1995, Use of fluorescence in situ hybridization to determine the relationship between chromosome aberrations and cell survival in eight human fibroblast strains. International Journal of Radiation Biology, 68, 185-196.
  • TUCKER, S. L., GEARA, F. B., PETERS, L. J. and BROCK, W. A., 1996, How much could the radiotherapy dose be altered for individual patients based on a predictive assay of normal-tissue radiOSensitivity? Radiotherapy and Oncology, 38, 103-113.
  • TURBSSON, I., 1990, Individual variation and dose dependency in the progression rate of skin telangiectasia. International J ournal of Radiation Oncology, Biology, Physics, 19, 1569-1574.
  • TURBSSON, I., NYMAN, J., HOLMBERG, E. and ODBN, A., 1996, Prognostic factors for acute and late skin reactions in radiotherapy patients. International Journal of Radiation Oncology, Biology, PhysiCS, 36, 1065-1075.
  • WEST, C. M. L., DAVIDSON, S. E., HENDRY, J. H. and HUNTER, R. D., 1991, Prediction of cervical carcinoma response to radiotherapy. The Lancet, 338, 818.
  • WEST, C. M. L. and HENDRY, J. H. L., 1992, Intrinsic radiosensitivity as a predictor of patient response to radiotherapy. British Journal of Radiology, Suppl. 24, 146-152.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.